Franklin Resources
ONCY

Franklin Resources’s Oncolytics Biotech ONCY Stock Holding History

Franklin Resources’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71.3K Hold
69,842
– – ﹤0.01% 2973
2025
Q4 		$72.3K Hold
69,842
– – ﹤0.01% 2953
2025
Q3 		$71.2K Buy
69,842
+6,567
+10% +$7.36K ﹤0.01% 2972
2025
Q2 		$48.4K Hold
63,275
– – ﹤0.01% 2911
2025
Q1 		$34.7K Buy
63,275
+50,609
+400% +$37K ﹤0.01% 2879
2024
Q4 		$11.7K Buy
+12,666
New +$13.2K ﹤0.01% 2878

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources's ONCY Position: Q1 2026 in Review

Franklin Resources held its Oncolytics Biotech (ONCY) position steady in Q1 2026 at 69,842 shares worth $71.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2973.

Franklin Resources first reported a position in ONCY in Q4 2024 and has held it in 6 quarters since. The position peaked at $72.3K in Q4 2025. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Franklin Resources held 69,842 shares of Oncolytics Biotech worth $71.3K as of Q1 2026.
  • Franklin Resources left its Oncolytics Biotech share count unchanged in Q1 2026.
  • Oncolytics Biotech made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2973 holding.
  • Franklin Resources first reported a position in Oncolytics Biotech in Q4 2024 and has held it in 6 quarters since.
  • Franklin Resources's Oncolytics Biotech position peaked at $72.3K in Q4 2025.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.